• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US BIOSTOP G CEM RESTR 12MM; CEMENT CENTRALIZER/PLUG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US BIOSTOP G CEM RESTR 12MM; CEMENT CENTRALIZER/PLUG Back to Search Results
Catalog Number 546312000
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pocket Erosion (2013); Unspecified Tissue Injury (4559); Bone Notching (4890)
Date of Event 11/06/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
It was reported that patient underwent revision surgery, requiring extensive debridement.Extensive bone erosion was noted on the medial and lateral femoral condyles as well as along the medial tibial plateau requiring bone grafting to correct.Granulation tissue indicative of loosening was noted.The femoral and tibial sides were noted to be loose - interface not identified.The patella was removed and underneath small cysts were identified and removed before replacing.A fracture of the femoral stem and the connecting screw occurred without trauma.The connecting screw between the femoral shield and the femoral shaft is affected.The revision went smoothly.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary
=
> user report received bfarm case 1652/25 in the above-mentioned partially coupled, cemented revision prosthesis, a fracture of the femoral stem and the connecting screw occurred without trauma.Femoral stem and the connecting screw in the connection area to the femoral shield the product was not returned to j&j medtech orthopaedics, however photos were provided for review.See attachment (b)(4); (b)(4) used implant, (b)(4) photos explants.The photographs attached were reviewed, however they do not represent the reported product complaint.Therefore, the investigation could not draw any conclusions about the reported product due to the insufficient evidence provided.A manufacturing record evaluation was performed for the finished device [546312000 / 07b2701] number, and no non-conformances / manufacturing irregularities related to the malfunction were identified.As the device was not returned, an as-received condition could not be assessed, and a dimensional inspection and document/specification review were not completed.The overall complaint was not confirmed as the photographs provided are not representative of the reported product and adverse event.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the complaint condition.As part of j&j medtech orthopaedics quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot
=
> 1) quantity manufactured: (b)(4).2) date of manufacture: production started on 9/14/2007 3) any anomalies or deviations identified in dhr: none.4) expiry date: 4/30/2010 5) ifu reference: ifu-315009 revision (b)(6) 2007.Device history review
=
> a manufacturing record evaluation was performed for the finished device [546312000 / 07b2701] number, and no non-conformances / manufacturing irregularities related to the malfunction were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOSTOP G CEM RESTR 12MM
Common Device Name
CEMENT CENTRALIZER/PLUG
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN 46582
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key21536917
Report Number1818910-2025-03549
Device Sequence Number20767360
Product Code JDK
UDI-Device Identifier10603295174561
UDI-Public(01)10603295174561(17)20100430(10)07B2701
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K943727
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2010
Device Catalogue Number546312000
Device Lot Number07B2701
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/14/2025
Supplement Date Received by Manufacturer06/11/2025
Initial Report FDA Received Date03/06/2025
Supplement Report FDA Received Date06/13/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/14/2007
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
9610921-11/29/2022-001-R
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PFC SIGMA FEM POST AUG SZ3 4MM.; PFC SIGMA TIB TRAY CEM SZ3.; PFC*SIGMA DIS AUG 4MM, SZ3, RGHT.; PFC*SIGMA DIS AUG 4MM, SZ3, RGHT.; PFC*SIGMA TC3 FEM RT SZ3.; PFC*SIGMA TC3 INS 22.5MM, SZ 3.; PFC*SIGMA/OV/DOME PAT 3PEG, 38.; PFCSIG +/-2FEMOFFSET STMBLT.; PFCSIG CEM FEM STEM 5DG13X90MM.; SIG TIB CEM STM 13X60 2/2. 5/3.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-